Literature DB >> 24549653

Diversity and evolution of spliceosomal systems.

Scott William Roy1, Manuel Irimia.   

Abstract

The intron-exon structures of eukaryotic nuclear genomes exhibit tremendous diversity across different species. The availability of many genomes from diverse eukaryotic species now allows for the reconstruction of the evolutionary history of this diversity. Consideration of spliceosomal systems in comparative context reveals a surprising and very complex portrait: in contrast to many expectations, gene structures in early eukaryotic ancestors were highly complex and "animal or plant-like" in many of their spliceosomal structures has occurred; pronounced simplification of gene structures, splicing signals, and spliceosomal machinery occurring independently in many lineages. In addition, next-generation sequencing of transcripts has revealed that alternative splicing is more common across eukaryotes than previously thought. However, much alternative splicing in diverse eukaryotes appears to play a regulatory role: alternative splicing fulfilling the most famous role for alternative splicing-production of multiple different proteins from a single gene-appears to be much more common in animal species than in nearly any other lineage.

Mesh:

Year:  2014        PMID: 24549653     DOI: 10.1007/978-1-62703-980-2_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Intron losses and gains in the nematodes.

Authors:  Ming-Yue Ma; Ji Xia; Kun-Xian Shu; Deng-Ke Niu
Journal:  Biol Direct       Date:  2022-06-05       Impact factor: 7.173

2.  Transcriptomic analysis of diplomonad parasites reveals a trans-spliced intron in a helicase gene in Giardia.

Authors:  Scott William Roy
Journal:  PeerJ       Date:  2017-01-05       Impact factor: 2.984

Review 3.  Domestication of self-splicing introns during eukaryogenesis: the rise of the complex spliceosomal machinery.

Authors:  Julian Vosseberg; Berend Snel
Journal:  Biol Direct       Date:  2017-12-01       Impact factor: 4.540

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.